Cargando…
Clinical Trials of Cellular Therapies in Solid Tumors
SIMPLE SUMMARY: Cell therapy approaches, including adoptive cell therapy with engineered T cells remains challenging in the clinical setting of solid tumors. Clinical results have not been encouraging so far, with a general lack of significant therapeutic response and presence of on-target off-tumor...
Autores principales: | Secondino, Simona, Canino, Costanza, Alaimo, Domiziana, Muzzana, Marta, Galli, Giulia, Borgetto, Sabrina, Basso, Sabrina, Bagnarino, Jessica, Pulvirenti, Chiara, Comoli, Patrizia, Pedrazzoli, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10377409/ https://www.ncbi.nlm.nih.gov/pubmed/37509328 http://dx.doi.org/10.3390/cancers15143667 |
Ejemplares similares
-
Immunotherapeutic Intervention against Sarcomas
por: Pedrazzoli, Paolo, et al.
Publicado: (2011) -
Testicular tumors in the “elderly” population
por: Secondino, Simona, et al.
Publicado: (2022) -
Lights and shadows on the role of rhG-CSF in cancer patients during the COVID-19 pandemic and future perspectives of research
por: Lasagna, Angioletta, et al.
Publicado: (2021) -
Management of PTLD After Hematopoietic Stem Cell Transplantation: Immunological Perspectives
por: Compagno, Francesca, et al.
Publicado: (2020) -
Harnessing T Cells to Control Infections After Allogeneic Hematopoietic Stem Cell Transplantation
por: Basso, Sabrina, et al.
Publicado: (2020)